From: TNF-α gene expression is increased following zinc supplementation in type 2 diabetes mellitus
Placebo (n = 10) | FSO (n = 10) | Zn (n = 11) | Zn + FSO (n = 9) | |
---|---|---|---|---|
IL-1β | ||||
Week 0 | 0.96 ± 0.11 | 1.72 ± 0.39 | 1.04 ± 0.15 | 0.91 ± 0.14 |
Week 12 | 0.97 ± 0.02 | 1.33 ± 0.06 | 1.46 ± 0.01 | 0.98 ± 0.06 |
Fold change | 1.08 ± 0.24 | 0.88 ± 0.43 | 1.51 ± 0.30 | 1.21 ± 0.35 |
IL-6 | ||||
Week 0 | 0.10 ± 0.12 | 0.13 ± 0.25 | 0.05 ± 0.36 | 0.17 ± 0.13 |
Week 12 | 0.08 ± 0.02 | 0.14 ± 0.08 | 0.08 ± 0.02 | 0.26 ± 0.10 |
Fold change | 0.97 ± 0.30 | 1.24 ± 0.29 | 1.46 ± 0.48 | 1.38 ± 023 |
TNF-α | ||||
Week 0 | 2.86 ± 0.15 | 3.85 ± 0.16 | 2.77 ± 0.26 | 2.89 ± 0.18 |
Week 12 | 3.01 ± 0.12 | 3.16 ± 0.27 | 3.64 ± 0.25 | 3.09 ± 0.23 |
Fold change | 1.10 ± 0.12 | 0.88 ± 0.12 | 1.38 ± 0.16 | 1.14 ± 0.10 |